Despite a stellar share price run, MasTec's earnings quality is under scrutiny as persistent margin pressures from supply chain strains and strategic growth investments challenge its financial resilience. Investors are watching to see if management can steer the infrastructure giant toward more sustainable profitability.
Insulet Corporation (NASDAQ: PODD), the maker of the tubeless Omnipod insulin delivery system, is drawing investor attention with a potent mix of surging cash flow, market expansion, and a recurring revenue model. As the company capitalizes on recent regulatory wins and international growth, we examine the bull case and the risks ahead.
Karman Holdings, a recent NYSE entrant, is capturing Wall Street's attention with its pivotal role in next-generation missile and hypersonic systems. As U.S. defense budgets swell, can this premium-valued contractor justify its lofty multiples?
Despite a dominant position in analytical instruments, Waters Corporation faces headwinds from a slowing Chinese market and elevated debt. We examine the investment thesis for the life sciences tools provider, weighing its recurring revenue model against current valuation concerns.
Amidst a global push for reliable, carbon-free power, Centrus Energy Corp. (LEU) emerges as a critical supplier in the nuclear fuel chain. With its stock trading near backlog value and recent financial developments reducing execution risk, analysts see a clear path for growth, particularly as AI and data center energy demands surge.
Amid surging power demands from AI and electrification, NANO Nuclear Energy Inc. (NNE) is attracting bullish investor attention. Analysts point to its microreactor technology as a potential solution for decentralized, high-density energy needs, drawing comparisons to infrastructure giant NextEra Energy's growth trajectory.
Analysts have slashed Senseonics Holdings' 12-month price target by 40%, signaling heightened caution on the medical device maker's execution path following its stock split, despite maintaining a bullish long-term revenue model.
Quantum computing firm IonQ moves to acquire semiconductor foundry SkyWater Technology and optical communications specialist Skyloom Global, aiming to create the industry's first vertically integrated quantum company and gain tighter control over its core technology stack.
After a period of significant volatility, Neogen Corporation (NEOG) is showing signs of a sustainable operational turnaround under new leadership, with its latest quarterly results beating expectations and prompting a rare guidance upgrade.
With a key FDA decision on its non-nicotine therapy cytisinicline expected by mid-2026, Achieve Life Sciences (ACHV) is drawing bullish attention for its potential to address a massive unmet need in smoking cessation and tap into a newly opened market void.
While Wall Street obsesses over GLP-1 weight-loss drugs, Novo Nordisk's foundational diabetes business continues to deliver robust growth and exceptional returns on assets, presenting a durable investment thesis often overshadowed by the obesity narrative.
The banking, financial services, and insurance (BFSI) sector is poised for a pivotal transformation. As the initial wave of AI and cloud experimentation subsides, 2026 is emerging as the year the industry moves decisively toward operationalizing technology with robust governance, explainability, and compliance at its core.
At a high-profile industry gathering in Taipei, Nvidia CEO Jensen Huang highlighted the intense demand for advanced semiconductors, calling on TSMC to accelerate output as AI hardware needs strain global supply chains.
Kforce reports stronger-than-expected Q4 2025 results, citing the highest sequential growth in its tech business since 2022. The company sees early signs of a market recovery, fueled by client demand for flexible talent to tackle AI-driven projects and foundational IT work.
Revvity shares have faced significant pressure, down over 13% in the past year. A deep dive into its valuation reveals a stark contradiction: while a cash flow model suggests the stock is undervalued, its price-to-earnings multiple tells a different story. We examine the numbers and what they mean for investors.
Fabrinet's Q2 2026 earnings reveal a historic quarter, with revenue hitting $1.13B driven by explosive growth in high-performance computing and telecom. The company signals sustained momentum with aggressive capacity expansion.
Natural gas futures tumbled over 25% on Monday, hitting a three-week low, as a swift recovery in U.S. production and a warmer weather forecast alleviated supply concerns sparked by last week's Arctic blast.
With Advanced Micro Devices set to report Q4 results, derivatives traders are pricing in a significant post-earnings move, betting the chipmaker's momentum can extend its recent 25% surge from yearly lows.
A complaint alleging misconduct by Director of National Intelligence Tulsi Gabbard has been withheld from congressional oversight committees for eight months, her office citing an extended legal review. The delay, disputed by the complainant's attorney, raises questions about transparency and adherence to whistleblower protection laws within the nation's top intelligence office.
Elon Musk merges his space and AI ambitions under one roof as SpaceX finalizes the acquisition of xAI. The strategic move, combining Starlink, social platform X, and chatbot Grok, sets the stage for a landmark public offering and accelerates Musk's vision for off-planet data infrastructure.
